147 related articles for article (PubMed ID: 30219700)
1. The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.
Gandelman JS; Zic J; Dewan AK; Lee SJ; Flowers M; Cutler C; Pidala J; Chen H; Jagasia MH; Tkaczyk ER
Biol Blood Marrow Transplant; 2019 Feb; 25(2):279-286. PubMed ID: 30219700
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease.
Clark J; Yao L; Pavletic SZ; Krumlauf M; Mitchell S; Turner ML; Cowen EW
Arch Dermatol; 2009 Aug; 145(8):918-22. PubMed ID: 19687424
[TBL] [Abstract][Full Text] [Related]
4. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD
Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics of cutaneous chronic graft-versus-host diseases: a retrospective study in Korean patients.
Kim SJ; Choi JM; Kim JE; Cho BK; Kim DW; Park HJ
Int J Dermatol; 2010 Dec; 49(12):1386-92. PubMed ID: 21155089
[TBL] [Abstract][Full Text] [Related]
6. Oral disease profiles in chronic graft versus host disease.
Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Cowen EW; Naik H; Datiles M; Stratton P; Gress RE; Pavletic SZ
J Dent Res; 2015 Apr; 94(4):547-54. PubMed ID: 25740857
[TBL] [Abstract][Full Text] [Related]
7. Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses.
Martires KJ; Baird K; Citrin DE; Hakim FT; Pavletic SZ; Cowen EW
Arch Dermatol; 2011 Sep; 147(9):1081-6. PubMed ID: 21931046
[TBL] [Abstract][Full Text] [Related]
8. Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease.
Ghosh S; Baker L; Chen F; Khera Z; Vain A; Zhang K; Hood A; Smith H; Chen H; Jagasia M; Tkaczyk E
Arch Dermatol Res; 2023 Nov; 315(9):2545-2554. PubMed ID: 37227518
[TBL] [Abstract][Full Text] [Related]
9. Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
Cardones AR; Sullivan KM; Green C; Chao NJ; Rowe-Nichols K; Bañez LL; Burton CS; Horwitz ME; Long GD; Rao CL; Sarantopoulos S; Sidhu-Malik N; Sung AD; Hall RP
JAMA Dermatol; 2019 Jul; 155(7):833-837. PubMed ID: 30994873
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
11. Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation.
Busca A; Rendine S; Locatelli F; Sizzano F; Dall'omo AM; Rossi G; Falda M
Hematology; 2005 Feb; 10(1):1-10. PubMed ID: 16019440
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study.
Shreberk-Hassidim R; Neumark M; Greenberger S; Goldstein G; Hassidim A; Dukler Y; Maly A; Stepensky P; Molho-Pessach V
Acta Derm Venereol; 2018 Feb; 98(2):206-211. PubMed ID: 29057425
[TBL] [Abstract][Full Text] [Related]
13. Histologic and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease.
Marks DH; Naftulin JS; Penzi LR; Manatis-Lornell A; Yasuda MR; Chapman CM; Rao SR; Saavedra A; Senna MM
J Am Acad Dermatol; 2019 Nov; 81(5):1134-1141. PubMed ID: 31454500
[TBL] [Abstract][Full Text] [Related]
14. Exuberant granulation tissue associated with chronic graft-versus-host disease after transplantation of peripheral blood progenitor cells.
Barnadas MA; Brunet S; Sureda A; López R; Curell R; Sierra J; Alomar A
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):876-9. PubMed ID: 10534676
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of female genital chronic graft-versus-host disease symptoms, signs, diagnosis and treatment.
Smith Knutsson E; Björk Y; Broman AK; Helström L; Nicklasson M; Brune M; Sundfeldt K
Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1122-1129. PubMed ID: 29752810
[TBL] [Abstract][Full Text] [Related]
16. Myofibroblasts generated in culture from sclerotic skin lesions of a patient with extensive chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation are of recipient origin.
Goussetis E; Spiropoulos A; Theodosaki M; Stefanaki K; Petrakou E; Graphakos S
Stem Cells Dev; 2010 Sep; 19(9):1285-7. PubMed ID: 20001597
[TBL] [Abstract][Full Text] [Related]
17. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients.
Noce CW; Gomes A; Copello A; Barbosa RD; Sant'anna S; Moreira MC; Correa ME; Maiolino A; Torres SR
Gen Dent; 2011; 59(6):458-62; quiz 463-4. PubMed ID: 22313917
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C
Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.
Lamby P; Wolff D; Mielke S; Grigoleit GU; Ljungman P; Hilgendorf I; Holler E; Holler B; Weber D; Herr W; Schiltz D; Klein S; Graf S; Bjornhagen-Safwenberg V; Dolderer J; Prantl L
Ann Hematol; 2019 Aug; 98(8):1867-1875. PubMed ID: 30993415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
